Insufficient scRNA-seq data for expression of CAVIN4 at single-cell level.
Insufficient scRNA-seq data for expression of CAVIN4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 82% | 106.23 | 2160 / 2642 | 74% | 1.56 | 519 / 705 |
muscle | 100% | 6497.12 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.33 | 1 / 1 |
heart | 97% | 1754.16 | 839 / 861 | 0% | 0 | 0 / 0 |
thymus | 69% | 69.05 | 453 / 653 | 16% | 0.28 | 97 / 605 |
uterus | 32% | 29.54 | 55 / 170 | 36% | 1.83 | 163 / 459 |
lung | 41% | 37.34 | 235 / 578 | 25% | 0.50 | 294 / 1155 |
ovary | 7% | 4.92 | 12 / 180 | 50% | 1.18 | 213 / 430 |
skin | 16% | 17.42 | 282 / 1809 | 39% | 1.07 | 186 / 472 |
bladder | 24% | 25.76 | 5 / 21 | 29% | 0.57 | 144 / 504 |
esophagus | 13% | 16.43 | 188 / 1445 | 37% | 0.74 | 67 / 183 |
pancreas | 1% | 0.61 | 3 / 328 | 38% | 1.07 | 68 / 178 |
eye | 0% | 0 | 0 / 0 | 38% | 0.92 | 30 / 80 |
intestine | 27% | 21.99 | 256 / 966 | 7% | 0.15 | 35 / 527 |
prostate | 22% | 62.18 | 54 / 245 | 10% | 0.92 | 50 / 502 |
tonsil | 0% | 0 | 0 / 0 | 31% | 1.70 | 14 / 45 |
stomach | 19% | 14.35 | 67 / 359 | 8% | 0.16 | 23 / 286 |
breast | 5% | 6.74 | 25 / 459 | 18% | 0.43 | 206 / 1118 |
blood vessel | 23% | 26.01 | 313 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.22 | 4 / 29 |
liver | 2% | 1.80 | 5 / 226 | 11% | 0.21 | 43 / 406 |
kidney | 6% | 3.87 | 5 / 89 | 7% | 0.19 | 61 / 901 |
adipose | 6% | 5.29 | 78 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 1.10 | 3 / 258 | 2% | 0.03 | 5 / 230 |
peripheral blood | 0% | 0.98 | 4 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.27 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0030154 | Biological process | cell differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0042383 | Cellular component | sarcolemma |
GO_0016528 | Cellular component | sarcoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030018 | Cellular component | Z disc |
GO_0005886 | Cellular component | plasma membrane |
GO_0005901 | Cellular component | caveola |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | CAVIN4 |
Protein name | Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein) |
Synonyms | MURC |
Description | FUNCTION: Modulates the morphology of formed caveolae in cardiomyocytes, but is not required for caveolar formation. Facilitates the recruitment of MAPK1/3 to caveolae within cardiomyocytes and regulates alpha-1 adrenergic receptor-induced hypertrophic responses in cardiomyocytes through MAPK1/3 activation. Contributes to proper membrane localization and stabilization of caveolin-3 (CAV3) in cardiomyocytes (By similarity). Induces RHOA activation and activates NPPA transcription and myofibrillar organization through the Rho/ROCK signaling pathway . . |
Accessions | Q5BKX8 ENST00000307584.6 |